Enhancing Anticancer Effects: Targeted Doxorubicin Delivery Using UiO-66-NH2-FA Metal-Organic Framework Combined with Autophagy Inhibition by Hydroxychloroquine in Colorectal Cancer Cells
Adeleh Saffar, Tahereh Rohani Bastami, Amir Ebrahimi, Sonia Iranpour, Mohammad Hasan Mollaei, Ahmad Reza Bahrami, Maryam M. Matin
{"title":"Enhancing Anticancer Effects: Targeted Doxorubicin Delivery Using UiO-66-NH2-FA Metal-Organic Framework Combined with Autophagy Inhibition by Hydroxychloroquine in Colorectal Cancer Cells","authors":"Adeleh Saffar, Tahereh Rohani Bastami, Amir Ebrahimi, Sonia Iranpour, Mohammad Hasan Mollaei, Ahmad Reza Bahrami, Maryam M. Matin","doi":"10.1007/s10856-025-06913-3","DOIUrl":null,"url":null,"abstract":"<div><p>The use of targeted drug delivery systems to accumulate medications in cancer cells, along with the simultaneous application of multiple drugs, can facilitate the administration of optimal doses, leading to more efficient treatment as well as reduced side effects. We fabricated zirconium-based UiO-66-NH<sub>2</sub> metal-organic framework (MOF) nanoparticles (NPs) with folic acid (FA) conjugated onto their surface for targeted delivery of doxorubicin (DOX), and smart drug release within tumor cells. Following the physicochemical characterization of the prepared NPs, the drug release profile was investigated in simulated media with pH 5.4 and 7.4. Subsequently, the internalization and anticancer effects of the NPs were evaluated in HT-29 and HEK-293 cells to assess their selectivity. Simultaneous treatment of HT-29 cells with FA-decorated NPs and hydroxychloroquine (HCQ), an autophagy inhibitor, was performed to sensitize cancer cells. The synergistic effects of combined treatment were assessed through MTT assay and autophagy flux detection. UiO-66-NH<sub>2</sub>-FA@DOX NPs with a surface area of 323 m²/g and a high loading capacity of 36.25% showed a pH-dependent release with a substantial increase in acidic condition. Higher uptake of targeted NPs in HT-29 cells led to higher cytotoxicity and apoptosis. The combination of HCQ and targeted NPs increased cytotoxic effects against HT-29 cells compared to treatment with targeted NPs alone. Acridine orange staining revealed different patterns of autophagy flux in the co-administered drug groups. This study suggests that our DOX-loaded targeted nanocarrier enhances the therapeutic efficacy through localized drug delivery and reduced potential side effects compared to conventional DOX treatment. Its combination with HCQ may offer a promising strategy for safer and more effective colorectal cancer therapy by enabling dose reduction of both agents. However, further in vivo studies are necessary to validate these findings.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":647,"journal":{"name":"Journal of Materials Science: Materials in Medicine","volume":"36 1","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s10856-025-06913-3.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Materials Science: Materials in Medicine","FirstCategoryId":"5","ListUrlMain":"https://link.springer.com/article/10.1007/s10856-025-06913-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The use of targeted drug delivery systems to accumulate medications in cancer cells, along with the simultaneous application of multiple drugs, can facilitate the administration of optimal doses, leading to more efficient treatment as well as reduced side effects. We fabricated zirconium-based UiO-66-NH2 metal-organic framework (MOF) nanoparticles (NPs) with folic acid (FA) conjugated onto their surface for targeted delivery of doxorubicin (DOX), and smart drug release within tumor cells. Following the physicochemical characterization of the prepared NPs, the drug release profile was investigated in simulated media with pH 5.4 and 7.4. Subsequently, the internalization and anticancer effects of the NPs were evaluated in HT-29 and HEK-293 cells to assess their selectivity. Simultaneous treatment of HT-29 cells with FA-decorated NPs and hydroxychloroquine (HCQ), an autophagy inhibitor, was performed to sensitize cancer cells. The synergistic effects of combined treatment were assessed through MTT assay and autophagy flux detection. UiO-66-NH2-FA@DOX NPs with a surface area of 323 m²/g and a high loading capacity of 36.25% showed a pH-dependent release with a substantial increase in acidic condition. Higher uptake of targeted NPs in HT-29 cells led to higher cytotoxicity and apoptosis. The combination of HCQ and targeted NPs increased cytotoxic effects against HT-29 cells compared to treatment with targeted NPs alone. Acridine orange staining revealed different patterns of autophagy flux in the co-administered drug groups. This study suggests that our DOX-loaded targeted nanocarrier enhances the therapeutic efficacy through localized drug delivery and reduced potential side effects compared to conventional DOX treatment. Its combination with HCQ may offer a promising strategy for safer and more effective colorectal cancer therapy by enabling dose reduction of both agents. However, further in vivo studies are necessary to validate these findings.
期刊介绍：
The Journal of Materials Science: Materials in Medicine publishes refereed papers providing significant progress in the application of biomaterials and tissue engineering constructs as medical or dental implants, prostheses and devices. Coverage spans a wide range of topics from basic science to clinical applications, around the theme of materials in medicine and dentistry. The central element is the development of synthetic and natural materials used in orthopaedic, maxillofacial, cardiovascular, neurological, ophthalmic and dental applications. Special biomedical topics include biomaterial synthesis and characterisation, biocompatibility studies, nanomedicine, tissue engineering constructs and cell substrates, regenerative medicine, computer modelling and other advanced experimental methodologies.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
